Director/PDMR Shareholding

Assura PLC
12 July 2024
 

12 July 2024

Assura plc

("the Company")

Notification of transaction by Persons Discharging Managerial Responsibilities ("PDMRs") and connected persons

Assura plc ("Assura"), the specialist healthcare property investor and developer announces that on 8 July 2024, the following named PDMRs were granted the following share options over Ordinary Shares of 10 pence each in the Company under the Company's Performance Share Plan ("PSP").

PDMR

Position

Number of Share Options Granted

Jonathan Murphy

CEO

1,905,505

Jayne Cottam

CFO

1,269,599

These options are subject to three performance conditions which will be determined after the 2026/27 financial year.  33% of the option shares are subject to a Total Shareholder Return ("TSR") performance condition, 33% of the option shares are subject to a Total Accounting Return ("TAR") performance condition and the remaining 33% are subject to ESG measures related to portfolio energy reduction targets (energy usage intensity, "EUI") and net zero carbon developments.  Details of the performance conditions are set out in the Company's Directors' Remuneration Report for 2023/24.

In addition, the following PDMRs were granted restricted share options over Ordinary Shares of 10 pence each in the company under the PSP.

PDMR

Position

Number of Restricted Share Options Granted

Orla Ball

General Counsel

88,474

Robert James

Group Development Director

88,474

Sarah Taylor

Chief People Officer

88,474

The Notification of Dealing Forms can be found below.

This notification is made in accordance with the Market Abuse Regulation.

Notification of dealing form

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jonathan Murphy

2

Reason for the notification

 

a)

Position/status

 

CEO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Share options over ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Grant of options under the PSP

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£NIL GBP

 

1,905,505

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£NIL GBP

 

 

1,905,505

 

£NIL GBP

e)

Date of the transaction

 

08/07/2024

f)

Place of the transaction

 

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jayne Cottam

2

Reason for the notification

 

a)

Position/status

 

CFO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Share options over ordinary shares of 10 pence each

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Grant of options under the PSP

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£NIL GBP

 

1,269,599

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£NIL GBP

 

 

1,269,599

 

£NIL GBP

e)

Date of the transaction

 

08/07/2024

f)

Place of the transaction

 

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Orla Ball

2

Reason for the notification

 

a)

Position/status

 

General Counsel

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Share options over ordinary shares of 10 pence each

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Grant of restricted share options under the PSP

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£NIL GBP

 

88,474

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£NIL GBP

 

 

88,474

 

£NIL GBP

e)

Date of the transaction

 

08/07/2024

f)

Place of the transaction

 

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Robert James

2

Reason for the notification

 

a)

Position/status

 

Group Development Director

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Share options over ordinary shares of 10 pence each

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Grant of restricted share options under the PSP

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£NIL GBP

 

88,474

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£NIL GBP

 

 

88,474

 

£NIL GBP

e)

Date of the transaction

 

08/07/2024

f)

Place of the transaction

 

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Sarah Taylor

2

Reason for the notification

 

a)

Position/status

 

Chief People Officer

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Share options over ordinary shares of 10 pence each

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Grant of restricted share options under the PSP

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£NIL GBP

 

88,474

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£NIL GBP

 

 

88,474

 

£NIL GBP

e)

Date of the transaction

 

08/07/2024

f)

Place of the transaction

 

XLON



 

- Ends -

For more information, please contact:

 

Assura plc

 

Tel: 0161 515 2043

Orla Ball, General Counsel

David Purcell, Investor Relations Director

 

Email: Investor@assura.co.uk

FGS Global

Gordon Simpson
Grace Whelan

Tel: 0207 251 3801

Email: Assura@fgsglobal.com

 

Notes to Editors

Assura plc is the UK's leading specialist healthcare property investor and developer. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders.

At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Assura (AGR)
UK 100

Latest directors dealings